Stelexis Therapeutics: Cancer Treatment & Biotech
Patrick Doyle is the CEO of Stelexis Therapeutics, a private biotechnology company based in New York. Patrick spoke with us about the company and the future of cancer treatments.
What recent advancements have you seen in…
